Literature DB >> 25561694

Cardiovascular disease risk factors after early-onset preeclampsia, late-onset preeclampsia, and pregnancy-induced hypertension.

Jan H W Veerbeek1, Wietske Hermes2, Anath Y Breimer2, Bas B van Rijn2, Steven V Koenen2, Ben W Mol2, Arie Franx2, Christianne J M de Groot2, Maria P H Koster2.   

Abstract

Observational studies have shown an increased lifetime risk of cardiovascular disease (CVD) in women who experienced a hypertensive disorder in pregnancy. This risk is related to the severity of the pregnancy-related hypertensive disease and gestational age at onset. However, it has not been investigated whether these differences in CVD risk factors are already present at postpartum cardiovascular screening. We evaluated postpartum differences in CVD risk factors in 3 subgroups of patients with a history of hypertensive pregnancy. We compared the prevalence of common CVD risk factors postpartum among 448 women with previous early-onset preeclampsia, 76 women with previous late-onset preeclampsia, and 224 women with previous pregnancy-induced hypertension. Women with previous early-onset preeclampsia were compared with women with late-onset preeclampsia and pregnancy-induced hypertension and had significantly higher fasting blood glucose (5.29 versus 4.80 and 4.83 mmol/L), insulin (9.12 versus 6.31 and 6.7 uIU/L), triglycerides (1.32 versus 1.02 and 0.97 mmol/L), and total cholesterol (5.14 versus 4.73 and 4.73 mmol/L). Almost half of the early-onset preeclampsia women had developed hypertension, as opposed to 39% and 25% of women in the pregnancy-induced hypertension and late-onset preeclampsia groups, respectively. Our data show differences in the prevalence of common modifiable CVD risk factors postpartum and suggest that prevention strategies should be stratified according to severity and gestational age of onset for the hypertensive disorders of pregnancy.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  hypertension; prevention

Mesh:

Substances:

Year:  2015        PMID: 25561694     DOI: 10.1161/HYPERTENSIONAHA.114.04850

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  77 in total

Review 1.  Pathophysiology of preeclampsia: an angiogenic imbalance and long-lasting systemic vascular dysfunction.

Authors:  Takuji Tomimatsu; Kazuya Mimura; Masayuki Endo; Keiichi Kumasawa; Tadashi Kimura
Journal:  Hypertens Res       Date:  2016-11-10       Impact factor: 3.872

2.  Doppler ultrasound and photoplethysmographic assessment for identifying pregnancy-induced hypertension.

Authors:  Xiurong Sun; Fangming Su; Xuelin Chen; Qihui Peng; Xiaomin Luo; Xinghai Hao
Journal:  Exp Ther Med       Date:  2019-12-31       Impact factor: 2.447

Review 3.  Preeclampsia and Pregnancy-Related Hypertensive Disorders.

Authors:  S Ananth Karumanchi; Joey P Granger
Journal:  Hypertension       Date:  2015-12-22       Impact factor: 10.190

Review 4.  Assessing and Modifying Coronary Artery Disease Risk in Women.

Authors:  Amy Sarma; Nandita S Scott
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-07

Review 5.  Cerebrovascular Dysfunction in Preeclamptic Pregnancies.

Authors:  Erica Shields Hammer; Marilyn J Cipolla
Journal:  Curr Hypertens Rep       Date:  2015-08       Impact factor: 5.369

Review 6.  Preeclampsia: Updates in Pathogenesis, Definitions, and Guidelines.

Authors:  Elizabeth Phipps; Devika Prasanna; Wunnie Brima; Belinda Jim
Journal:  Clin J Am Soc Nephrol       Date:  2016-04-19       Impact factor: 8.237

Review 7.  Preeclampsia and Vascular Function: A Window to Future Cardiovascular Disease Risk.

Authors:  Davaasambuu Enkhmaa; Danielle Wall; Puja K Mehta; Jennifer J Stuart; Janet Wilson Rich-Edwards; C Noel Bairey Merz; Chrisandra Shufelt
Journal:  J Womens Health (Larchmt)       Date:  2016-01-18       Impact factor: 2.681

Review 8.  The Role of Sex-Specific Risk Factors in the Risk Assessment of Atherosclerotic Cardiovascular Disease for Primary Prevention in Women.

Authors:  Priya M Freaney; Sadiya S Khan; Donald M Lloyd-Jones; Neil J Stone
Journal:  Curr Atheroscler Rep       Date:  2020-07-16       Impact factor: 5.113

Review 9.  Research Recommendations From the National Institutes of Health Workshop on Predicting, Preventing, and Treating Preeclampsia.

Authors:  Christine Maric-Bilkan; Vikki M Abrahams; S Sonia Arteaga; Ghada Bourjeily; Kirk P Conrad; Janet M Catov; Maged M Costantine; Brian Cox; Vesna Garovic; Eric M George; Alison D Gernand; Arun Jeyabalan; S Ananth Karumanchi; Aaron D Laposky; Menachem Miodovnik; Megan Mitchell; Victoria L Pemberton; Uma M Reddy; Mark K Santillan; Eleni Tsigas; Kent L R Thornburg; Kenneth Ward; Leslie Myatt; James M Roberts
Journal:  Hypertension       Date:  2019-04       Impact factor: 10.190

10.  Postpartum metabolic syndrome after gestational hypertension and preeclampsia, a prospective cohort study.

Authors:  Alfred O Osoti; Stephanie T Page; Barbra A Richardson; Brandon L Guthrie; John Kinuthia; Stephen J Polyak; Carey Farquhar
Journal:  Pregnancy Hypertens       Date:  2019-08-19       Impact factor: 2.899

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.